Delivery Order SPE2DB20D1004-SPE2DB25FNCQK

Award Date 11/12/24
Potential Completion Date 11/13/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,981.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,089,803 units of the prescription drug Ezetimibe 10 mg tablets. The contract has a completion date of January 30, 2025 and is structured as a Firm Fixed Price Delivery Order. The contract was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,356.71, is for the delivery of 500 tablets of the pharmaceutical product Ezetimibe 10 mg. It is a firm fixed-price contract with a completion date of February 13, 2023. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award is for the delivery of Ezetimibe 10 mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $1,383.46 delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 8, 2024, with a completion date of November 12, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,346.31 Firm Fixed Price delivery order is for the supply of Ezetimibe 10 mg tablets. The contract is not set aside for any specific business type. It is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999 through December 2025, which enables the agency to efficiently...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,159.12 firm fixed-price contract is for the delivery of 4,566,670,756 tablets of the prescription drug ezetimibe 10 mg. The contract has a completion date of December 11, 2024 and does not utilize any set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,050.23 firm fixed-price delivery order is for the supply of 4562437463 EZETIMIBE 10 MG TABLET 500S, a pharmaceutical product, with an ultimate completion date of October 11, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, worth $2,909.70, is to provide 500 tablets of the drug ezetimibe 10 mg. The award has an ultimate completion date of April 25, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for...
This federal contract award is for the delivery of Ezetimibe 10 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc. The contract has a ceiling value of $15,455.86 and is a firm fixed-price delivery order contract. There is no set-aside designation mentioned, indicating this was a full and open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a $2,269.98 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA) for the supply of 4564804826 - Ezetimibe 10 mg Tablet 90s. The award has a completion date of June 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of ezetimibe 10 mg tablets. The contract has a firm fixed price of $1,659.91 and a period of performance through September 26, 2024. The award is not associated with a set-aside program. As a major pharmaceutical distributor, AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to provide a wide range of essential...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB25FNCQK
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ezetimibe 10 mg tablets. The contract has a ceiling value of $1,740.35 and a period of performance through November 13, 2024. It is a Firm Fixed Price contract type. This delivery order is placed against a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not mention any set-aside requirements, indicating open competition.

Generated 2/27/25, 12:16 PM